Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy

BACKGROUND: Evaluate morbidities and “quality” of fiducial marker placement in primary liver tumours (hepatocellular carcinoma [HCC]) for CyberKnife. MATERIALS AND METHODS: Thirty-six HCC with portal vein thrombosis (PVT) were evaluated for “quality” of fiducial placement, placement time, pain score...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Debnarayan, Kataki, Kaushik Jagannath, George, Shibu, Reddy, Sruthi K., Sashidharan, Ajay, Kannan, Rajesh, Madhavan, Ram, Nair, Haridas, Tatineni, Tushar, Holla, Raghavendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785839/
https://www.ncbi.nlm.nih.gov/pubmed/33249803
http://dx.doi.org/10.3857/roj.2020.00472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785839/
https://www.ncbi.nlm.nih.gov/pubmed/33249803
http://dx.doi.org/10.3857/roj.2020.00472

Ejemplares similares